Cargando…

The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies

The purpose of review is to review the current status of positron emission tomography (PET) molecular imaging of serotonergic system in Parkinson’s patients who experience levodopa-induced (LIDs) and graft-induced dyskinesias (GIDs). PET imaging studies have shown that Parkinson’s disease is charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Gennaro, Niccolini, Flavia, Politis, Marios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2017
Materias:	Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060863/ https://www.ncbi.nlm.nih.gov/pubmed/29264660 http://dx.doi.org/10.1007/s00702-017-1823-7

Ejemplares similares

Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2019)

Dementia spectrum disorders: lessons learnt from decades with PET research
por: Wilson, Heather, et al.
Publicado: (2019)

Current status of PET imaging in Huntington’s disease
por: Pagano, Gennaro, et al.
Publicado: (2016)

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Pagano, Gennaro, et al.
Publicado: (2017)

Neuroimaging of Sleep Disturbances in Movement Disorders
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease
por: Falkenburger, Björn, et al.
Publicado: (2022)

Cholinergic imaging in dementia spectrum disorders
por: Roy, Roman, et al.
Publicado: (2016)

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism
por: Niccolini, Flavia, et al.
Publicado: (2016)

Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
por: Yousaf, Tayyabah, et al.
Publicado: (2019)

On the neuronal circuitry mediating l-DOPA-induced dyskinesia
por: Cenci, M. Angela, et al.
Publicado: (2018)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression
por: Spigolon, Giada, et al.
Publicado: (2018)

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
por: Zhou, Xun, et al.
Publicado: (2019)

Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2021)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018)

Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease
por: Fan, Qian-Ya, et al.
Publicado: (2022)

Opioidergic Modulation of Striatal Circuits, Implications in Parkinson's Disease and Levodopa Induced Dyskinesia
por: Sgroi, Stefania, et al.
Publicado: (2018)

Improvement of Deep Brain Stimulation in Dyskinesia in Parkinson's Disease: A Meta-Analysis
por: Liu, Yun, et al.
Publicado: (2019)

Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients
por: Polychronis, Sotirios, et al.
Publicado: (2019)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily Living
por: Goubault, Etienne, et al.
Publicado: (2019)

Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients
por: Aljuaid, Maram, et al.
Publicado: (2019)

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
por: Politis, Marios, et al.
Publicado: (2011)

Serotonergic Antidepressants and Risk for Traumatic Intracranial Bleeding
por: Isokuortti, Harri, et al.
Publicado: (2021)

Amantadine ER (Gocovri(®)) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease
por: Hauser, Robert A., et al.
Publicado: (2021)

Concussion-Induced Oromandibular Dyskinesia
por: Zhang, Brenda, et al.
Publicado: (2023)

The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023)

Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review
por: Wu, Yi, et al.
Publicado: (2021)

Evaluation of the Direct Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Levodopa-Induced On-Dyskinesia in Parkinson's Disease
por: Li, Jiping, et al.
Publicado: (2021)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Life style and Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2022)

Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease
por: Wang, Lu, et al.
Publicado: (2021)

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease
por: Niccolini, Flavia, et al.
Publicado: (2019)

The Rodent Models of Dyskinesia and Their Behavioral Assessment
por: Peng, Qiwei, et al.
Publicado: (2019)

Treatment of Parkinson’s disease in the advanced stage
por: Ossig, C., et al.
Publicado: (2013)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Parkinson’s disease between internal medicine and neurology
por: Csoti, Ilona, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dfp3g64n1o2cbdb32k4anob56r